Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Remdesivir Approved by FDA Experimental Antiviral Jan/18/2023 73 5
Mesenchymal stem cells Potential treatment - clinical evidence Experimental Other treatment Oct/17/2022 63 3
Bamlanivimab Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022 11 16
BNT162b2 Approved by FDA Experimental Vaccine Jun/22/2022 65 0
mRNA-1273 Emergency use authorization Experimental Vaccine Jun/22/2022 27 1
Convalescent plasma Emergency use authorization Experimental Antiviral May/16/2022 43 10
BBIBP-CorV Potential treatment - clinical evidence Experimental Vaccine Dec/23/2021 3 1
Corticosteroids Potential treatment - clinical evidence Used to treat other disease Other treatment Dec/16/2021 18 8
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
NVX-CoV2373 Potential treatment - clinical evidence Experimental Vaccine Apr/07/2021 6 0
Excel (.xslx) CSV (.csv)